Director/PDMR Shareholding
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases, announces that award of restricted share units ("RSUs") granted by PureTech on 04 March 2024 to Robert Lyne, Chief Portfolio Officer ("PDMR") pursuant to its Performance Share Plan ("PSP") 25% of the shares vested on 01 February 2025.
The PDMR received vested ordinary shares (after deduction of shares for taxes) on 01 July 2025. The market price per ordinary share in the Company used to calculate the amount payable to the PDMR and the amount of shares to be issued to PDMR was 125.93 pence, being the average closing price of the Company's shares over the three-trading day period prior to issuance, and the exchange rate used to calculate the cash payment and amount of share settlement was £1: $1.37.
The Company has been notified that the PDMR has sold a total of 33,561 ordinary shares in the Company ("Shares") on 01 July 2025 at a price of 125.05 pence per share and bought on 01 July 2025, into his SIPP, a total of 33,561 Shares at the price of 125.78 pence per share.
The Company's total issued ordinary share capital is 257,927,489 shares after the share issuance to the PDMR, 17,639,479 shares of which are held in treasury by the Company.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Robert Lyne |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Portfolio Officer |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| b) | Nature of the transaction | Issuance of ordinary shares in settlement of certain vested RSUs under the PureTech Health Performance Share Plan and Share Disposal |
| c) | Price(s) and volume(s) | Recipient Price Amount Robert Lyne 0.01 GBP 33,561 ordinary shares |
| d) | Aggregated information - Aggregated volume - Price | Price Aggregate Volume 0.01 GBP 33,561 ordinary shares |
| e) | Date of the transaction | 01 July 2025 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.